Take heed to this text

The Monarch platform for robot-assisted urology procedures. | Supply: Johnson & Johnson’s Ethicon

Ethicon, a Johnson & Johnson MedTech firm, immediately introduced the primary robotic-assisted elimination of kidney stones utilizing the Monarch platform.

Auris Well being, an Ethicon subsidiary, acquired FDA clearance for Monarch for endourological procedures in Might 2022. The College of California, Irvine’s UCI Well being used the Monarch platform for urology to finish the primary process.

In keeping with a information launch, it’s the primary profitable robotically assisted, electromagnetic-guided percutaneous entry and mini-percutaneous nephrolithotomy process. Ethicon stated its research includes a collaboration with co-investigator Dr. Mihir Desai from the College of Southern California.

Robotics Summit & Expo (Might 10-11) returns to Boston

Martin Buehler, World Head of Robotics R&D at Johnson & Johnson MedTech, shall be keynoting the Robotics Summit on Might 11, 2023, at 10 AM. Buehler’s speak, “The Way forward for Surgical Robotics”, will give an inside take a look at the end-to-end growth of its Monarch and Ottava robotics platforms, in addition to technique and innovation cadence throughout surgical robotics for MedTech. 

“This scientific research is the primary on the earth to analysis and exhibit the potential for improved navigation, entry, clearance and management in mini-PCNL procedures utilizing the Monarch platform for urology,” stated Dr. Jaime Landman, chair of the UCI College of Drugs Division of Urology and director of the UCI Well being Kidney Stone & Kidney Illness Providers. “Along with probably serving to urologists obtain stone-free sufferers in a single process, this method might assist scale back the necessity for retreatment after kidney stone elimination and reduce dangers and complication charges.”

Ethicon’s scientific group led the primary case in its scientific research. It goals to gather efficiency knowledge on robotic mini-PCNL procedures to optimize Monarch and inform coaching and schooling.

“The prevalence of kidney stones stays excessive, and plenty of urologists search a brand new therapy possibility that reduces total retreatment and complication charges,” Desai stated. “In sufferers who require therapy by way of surgical procedure, shut to 1 in two would require retreatment inside 5 years.”

In regards to the Ethicon Monarch platform

Ethicon designed the Monarch robot-assisted surgical platform to allow urologists to succeed in and visualize areas inside the kidney with precision and management. The system provides one platform for supporting each ureteroscopic and PCNL procedures.

The Monarch platform for urology permits for navigation by way of the kidney with a handheld controller. Robotic help provides surgeons a strategy to exactly preserve instrument positions and carry out a number of duties concurrently. It makes use of a novel electromagnetic concentrating on platform to present urologists extra exact entry to the kidney.

In keeping with Ethicon, Monarch offers 80% much less radiation publicity throughout percutaneous entry in comparison with commonplace fluoroscopic-guided entry strategies. It additionally provides consistency with fewer needle sticks when acquiring entry, the corporate stated.

“After years of labor, we’re thrilled to be part of this primary scientific sequence which introduces a brand new therapy to enhance outcomes for sufferers in want,” Landman stated.